Beacon Capital Management LLC (Tennessee)’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.6K Hold
2025
Q1
$6.77K Hold
2024
Q4
$7.54K Hold
2024
Q3
$13.6K Hold
2024
Q2
$15K Hold
2024
Q1
$22.2K Hold
2023
Q4
$17.7K Buy